# ClinicalTrials.gov record NCT06303284

> PeptideScanner retained ClinicalTrials.gov record NCT06303284 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct06303284-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-03-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06303284-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06303284-teriparatide-v1.json
- Content SHA-256: `fbb895abec5b0b3b9df05be8d155cc9575c42f57932a24d23b10925c31def236`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06303284 ([`ctg-observation-nct06303284-2024-03-18-086924e370d5`](#source-ctg-observation-nct06303284-2024-03-18-086924e370d5))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06303284 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct06303284-2024-03-18-086924e370d5`](#source-ctg-observation-nct06303284-2024-03-18-086924e370d5))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06303284 at 2026-07-30T18:47:17.466Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct06303284-2024-03-18-086924e370d5`](#source-ctg-observation-nct06303284-2024-03-18-086924e370d5))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06303284-2024-03-18-086924e370d5`](#source-ctg-observation-nct06303284-2024-03-18-086924e370d5))

## Sources

<a id="source-ctg-observation-nct06303284-2024-03-18-086924e370d5"></a>
- **ClinicalTrials.gov record NCT06303284 · retained source version 2024-03-18:086924e370d52bd2799f1b0e3b3d90d9f840d4e3447f1881113f9c4cf359bffe** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06303284) (`ctg-observation-nct06303284-2024-03-18-086924e370d5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06303284." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06303284-teriparatide-v1.json SHA-256: fbb895abec5b0b3b9df05be8d155cc9575c42f57932a24d23b10925c31def236.